ArticleOxford medical case reports2022
Successful argon plasma coagulation treatment for self-expandable metal stent obstruction in colorectal cancer.
Article in Oxford medical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Self-expandable metal stents (SEMS) have often been used to treat malignant colorectal obstruction. But SEMS obstruction occurs due to the ingrowth of colorectal cancer. We report a case in which treatment with argon plasma coagulation (APC) was effective for SEMS obstruction. An 89-year-old man was admitted to our hospital for obstructive colorectal cancer. A SEMS was inserted and it improved malignant colorectal obstruction. Computed tomography scans demonstrated liver and lung metastases. His clinical cancer staging was IVb and he wished to receive palliative care. Two months later, SEMS obstruction occurred due to ingrowth of colorectal cancer. Treatment other than stent-in-stent SEMS insertion was considered because SEMS obstruction occurred in a short period of time. APC treatment was chosen and it improved the obstruction. The duration of stent patency was 62 days. APC is an option but it needs further studies to assess the safety of APC.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.